Royal Bank of Canada’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-585,122
| Closed | -$27.5M | – | 7516 |
|
|
2025
Q2 | $27.5M | Buy |
585,122
+491,910
| +528% | +$21.9M | 0.01% | 1312 |
|
|
2025
Q1 | $4.11M | Buy |
93,212
+33,869
| +57% | +$1.56M | ﹤0.01% | 2404 |
|
|
2024
Q4 | $2.14M | Sell |
59,343
-11,019
| -16% | -$385K | ﹤0.01% | 2979 |
|
|
2024
Q3 | $2.25M | Buy |
70,362
+2,708
| +4% | +$101K | ﹤0.01% | 2912 |
|
|
2024
Q2 | $2.55M | Buy |
67,654
+24,626
| +57% | +$1.04M | ﹤0.01% | 2723 |
|
|
2024
Q1 | $2.12M | Sell |
43,028
-16,832
| -28% | -$778K | ﹤0.01% | 2873 |
|
|
2023
Q4 | $2.19M | Buy |
59,860
+13,214
| +28% | +$345K | ﹤0.01% | 3003 |
|
|
2023
Q3 | $1.08M | Buy |
46,646
+4,659
| +11% | +$127K | ﹤0.01% | 3372 |
|
|
2023
Q2 | $1.1M | Buy |
41,987
+14,310
| +52% | +$376K | ﹤0.01% | 3287 |
|
|
2023
Q1 | $713K | Sell |
27,677
-1,290
| -4% | -$37.7K | ﹤0.01% | 3603 |
|
|
2022
Q4 | $752K | Buy |
28,967
+2,386
| +9% | +$58.8K | ﹤0.01% | 3743 |
|
|
2022
Q3 | $758K | Buy |
26,581
+1,447
| +6% | +$41.5K | ﹤0.01% | 3677 |
|
|
2022
Q2 | $619K | Sell |
25,134
-1,331
| -5% | -$48.7K | ﹤0.01% | 3898 |
|
|
2022
Q1 | $1.49M | Buy |
26,465
+479
| +2% | +$27.4K | ﹤0.01% | 3310 |
|
|
2021
Q4 | $1.61M | Buy |
25,986
+10,284
| +65% | +$681K | ﹤0.01% | 3355 |
|
|
2021
Q3 | $996K | Buy |
15,702
+12,713
| +425% | +$980K | ﹤0.01% | 3699 |
|
|
2021
Q2 | $247K | Sell |
2,989
-153
| -5% | -$11.6K | ﹤0.01% | 4890 |
|
|
2021
Q1 | $231K | Buy |
3,142
+2,269
| +260% | +$178K | ﹤0.01% | 4832 |
|
|
2020
Q4 | $64K | Buy |
873
+155
| +22% | +$9.98K | ﹤0.01% | 5562 |
|
|
2020
Q3 | $34K | Sell |
718
-30
| -4% | -$1.28K | ﹤0.01% | 5509 |
|
|
2020
Q2 | $31K | Buy |
748
+2
| +0.3% | +$71 | ﹤0.01% | 5418 |
|
|
2020
Q1 | $20K | Buy |
+746
| New | +$24.3K | ﹤0.01% | 5553 |
|
Other funds holding SWTX
Royal Bank of Canada's SWTX Position: Q3 2025 in Review
Royal Bank of Canada sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 585,122 shares — an estimated $27.5M sold.
Royal Bank of Canada first reported a position in SWTX in Q1 2020 and held it in 22 quarters. The position peaked at $27.5M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Royal Bank of Canada reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Royal Bank of Canada sold 585,122 SpringWorks Therapeutics shares in Q3 2025, an estimated $27.5M.
- Royal Bank of Canada first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 22 quarters.
- Royal Bank of Canada's SpringWorks Therapeutics position peaked at $27.5M in Q2 2025.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.